Eris Lifesciences Limited (BOM:540596)
India · Delayed Price · Currency is INR 1,398.15
+54.56 (4.06%)
At close: May 29, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 193.86 billion as of June 1, 2026. Its market cap has decreased by -2.23% in one year.
Market Cap
193.86B
Enterprise Value
216.70B
Revenue
31.15B
Ranking
n/a
PE Ratio
31.29
Stock Price
1,398.15
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 193.86B, an increase of 134.39%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 193.86B | -5.48% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |
| Jubilant Pharmova | 157.38B |
| Caplin Point Laboratories | 154.31B |
| Viyash Scientific | 113.07B |